Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.

Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society - 1 Jul 1999

Delladetsima J K, Boletis J N, Makris F, Psichogiou M, Kostakis A, Hatzakis A

Abstract excerpt

Fibrosing cholestatic hepatitis (FCH) has been described as a specific manifestation of hepatitis B virus (HBV) infection in liver allograft recipients characterized by a rapid progression to liver failure. Only sporadic cases have been reported in other immunocompromised groups infected with HBV and in a few transplant recipients with hepatitis C virus (HCV) infection. We present the occurrence of FCH in 4...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Azathioprine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholestasis, Intrahepatic

Share to Cyclosporine

Share to gamma-Glutamyltransferase

Share to Immunocompromised Host

Share to Methylprednisolone

Share to Viremia

Source

Identifiers

PMID: 10388502
DOI: 10.1002/lt.500050417

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.PMID 10388502Read ↗

Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation.Semantic proximity Read ↗

Fibrosing cholestatic hepatitis in a hepatitis B surface antigen carrier after renal transplantation.Semantic proximity Read ↗

A prospective study of hepatitis C virus infection in renal allograft recipients.Semantic proximity Read ↗

Impact of hepatitis C virus duration and hepatitis C virus genotypes on renal transplant patients: correlation with clinicopathological features.Semantic proximity Read ↗

Failure of hepatitis B surface antibody to protect acute fulminating hepatitis in a renal transplant recipient.Semantic proximity Read ↗

Hepatic failure due to fibrosing cholestatic hepatitis in a patient with pre-surface mutant hepatitis B virus and mixed connective tissue disease treated with prednisolone and chloroquine.Semantic proximity Read ↗

Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients.Semantic proximity Read ↗

Persistent hepatitis C virus infection after liver transplantation: clinical and virological features.Semantic proximity Read ↗

Histopathological features of hepatitis C in renal transplant candidates [see comment].Semantic proximity Read ↗

Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?Semantic proximity Read ↗

Cynomolgus monkeys are successfully and persistently infected with hepatitis E virus genotype 3 (HEV-3) after long-term immunosuppressive therapy.Semantic proximity Read ↗

Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.